According to a study published in Clinical Medicine Insights, medical cannabis in the form of oils or soft gels (oral) were cost-effective compared to all current knee pain therapies, including bracing, glucosamine, pharmaceutical-grade chondroitin oral non-steroidal anti-inflammatory drugs (NSAIDs), and opioids, at the lowest willingness-to-pay threshold.
Read more here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970188/
